Skip to main navigation Skip to search Skip to main content

Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study

  • on behalf of the TRANSFORM Investigators

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)1953-1963
Number of pages11
JournalTransplantation
Volume103
Issue number9
DOIs
StatePublished - Sep 1 2019

ASJC Scopus Subject Areas

  • Transplantation

Keywords

  • Humans
  • Middle Aged
  • Risk Factors
  • Graft Rejection/immunology
  • Immunosuppressive Agents/administration & dosage
  • Treatment Outcome
  • Calcineurin Inhibitors/administration & dosage
  • Kidney Transplantation/adverse effects
  • Time Factors
  • Graft Survival/drug effects
  • Adult
  • Cyclosporine/administration & dosage
  • Mycophenolic Acid/administration & dosage
  • Tacrolimus/administration & dosage
  • Drug Therapy, Combination
  • Everolimus/administration & dosage

Cite this